MONTEVIDEO, Dec 31 (UYPRESS) – The Ministry of Public Health has banned drugs containing Dextropropoxyphene, which is found in the following pain relievers: Analgion, Dioxadol, Novagesic, Panat, Dipyrone + dextropropoxyphene Larjan, and Dorixina Plus.
The official statement from the Ministry of Public Health states the following:
The Ministry of Public Health informs that it has carried out a review, through its Department of Medications and the Psychopharmaceutical and Narcotic Drugs Sector, advised by the National Advisory Committee on Pharmacovigilance, on the efficacy and safety of the drug Dextropropoxyphene.
Based on this, it is resolved:
1º) Prohibit the dispensing of pharmaceutical specialties containing dextropropoxyphene as of FEBRUARY 1, 2011 in community pharmacies and in hospital pharmacies for outpatients.
2º) Recommend to prescribing professionals (doctors and dentists) not to start new treatments with dextropropoxyphene.
3º) Review the analgesic treatment of patients who currently use dextropropoxyphene in order to progressively replace it with other available therapeutic alternatives.
4th) Inform patients that they should not discontinue this drug abruptly and without medical supervision.
5º) Restrict the use of pharmaceutical specialties containing dextropropoxyphene (oral and parenteral routes) to hospitalized patients.
6º) Revoke the registration and prohibit the marketing of suppository presentations that contain dextropropoxyphene in their formulation as of the date of this communication.
7º) Revoke the registration and definitively prohibit the commercialization of all pharmaceutical specialties that contain dextropropoxyphene in their formulation as of APRIL 1, 2011.
The trademarks available in our country are:
Dipyrone + dextroproposifen Larjan
UyPress – Uruguayan News Agency